Unresolved questions on venous thromboembolic disease. Venous thromboembolism (VTE) management in obese patients. Consensus statement of the French Society of Vascular Medicine (SFMV).
J Med Vasc
; 49(3-4): 170-175, 2024 Sep.
Article
em En
| MEDLINE
| ID: mdl-39278696
ABSTRACT
Obesity is an alarming worldwide public health issue and is defined as a body mass index (BMI) of 30kg/m2 or more. It is considered as a risk factor for first thrombotic event and is associated with a significant risk of recurrence. Consequently, obese patients are often treated by anticoagulant therapy but data from randomised control trial are scarce. We will review in this narrative review the state of the art of the prescription of anticoagulant for the prevention and treatment of venous thromboembolism (VTE) in obese patients.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tromboembolia Venosa
/
Anticoagulantes
/
Obesidade
Limite:
Humans
Idioma:
En
Revista:
J Med Vasc
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
França